<?xml version="1.0" encoding="UTF-8"?>
<p>Hydroxyurea, a deoxyribonucleic acid (DNA)-synthesis inhibitor, belongs to the antineoplastic medications. However, it may be used as a second-line drug for psoriasis and palmoplantar pustulosis
 <sup>
  <xref rid="bibr115-1759720X20947296" ref-type="bibr">115</xref>
 </sup> based on the ability to slow down the rapid division of keratinocytes. Bone marrow suppression is the major and common adverse effect of hydroxyurea.
</p>
